Your session is about to expire
← Back to Search
Transcranial Magnetic Stimulation for Smoking Addiction
Study Summary
This trial is testing if transcranial magnetic stimulation can help smokers quit by stimulating different parts of the brain. There will be a sham procedure to control for placebo effects.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2005 Phase 2 trial • 50 Patients • NCT00004980Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a serious mental illness.You have a current problem with using drugs, except for tobacco.You have a preference for menthol-flavored products.You have metal implants in your body.You have a diagnosis of tobacco addiction according to the latest guidelines.You have a condition that causes seizures.You use marijuana more than once a week.There are other situations that the researchers think could be unsafe for you to participate in the study.You should be in good overall health without any heart, liver, kidney, or autoimmune diseases, diabetes, or cancer.You must have been smoking for at least 1 year and currently smoke at least 10 cigarettes per day.You have a medical condition that could potentially make the study unsafe for you.You have used tobacco products other than cigarettes for more than 10 days in the past month.
- Group 1: TMS on v5
- Group 2: TMS on SFG
- Group 3: TMS on PPC
- Group 4: TMS on dlPFC
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many applicants are being considered for participation in this clinical experiment?
"Affirmative. Clinicaltrials.gov displays that this clinical trial, which had its first post on February 1st 2019, is still in demand of applicants. A total of 60 patients are currently needed at a single medical centre."
Who is qualified to participate in this research experiment?
"This research project is recruiting 60 individuals with nicotine addiction between ages 18 and 45. For admission, applicants need to fulfil the following criteria: age range of 18-45 years, gender identification as male or female, absence of cardiovascular issues, hepatic problems, renal conditions or autoimmune diseases; no diabetes diagnosis nor cancer history; at least one year smoking cigarettes daily (10 minimum)."
What are the study's primary objectives?
"This clinical trial is conducted over a 4 week period and its primary outcome will be measured with the Urge to Smoke Questionnaire. Secondary outcomes are observed by Post-stimulation MRI, Baseline Magnetic Resonance Imaging (MRI), and Post-stimulation Magnetic Resonance Imaging (MRI)."
Is there availability for participants in this experiment?
"Affirmative. According to the data on clinicaltrials.gov, this medical examination is currently enrolling patients and has been since February 1st 2019. The most recent update was performed on November 9th 2021 and it requires 60 participants from a single site for completion."
Does the eligibility criteria for this research endeavor include seniors aged 70 or above?
"Patients of legal age (18-45) are eligible to enroll in this trial. Alternatively, there are 4 trials available for those under 18 and 76 studies accommodating seniors over the age of 65."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger